Efficacy of Subcutaneous and Intravenous Tocilizumab in Noninfectious Uveitis
Saleema Kherani MD, MPH , Akhila Alapati MD, MBA , Tedi Begaj MD , Samantha Atlas RN , Anjum Koreishi MD , Timothy Janetos MD, MBA , Lisa J. Faia MD , Debra A. Goldstein MD
求助PDF
{"title":"Efficacy of Subcutaneous and Intravenous Tocilizumab in Noninfectious Uveitis","authors":"Saleema Kherani MD, MPH , Akhila Alapati MD, MBA , Tedi Begaj MD , Samantha Atlas RN , Anjum Koreishi MD , Timothy Janetos MD, MBA , Lisa J. Faia MD , Debra A. Goldstein MD","doi":"10.1016/j.ophtha.2024.10.010","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":"132 2","pages":"Pages 253-254"},"PeriodicalIF":13.1000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0161642024006304","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
引用
批量引用
皮下注射和静脉注射托昔单抗治疗非感染性葡萄膜炎的疗效
这项回顾性研究调查了皮下注射和静脉注射托珠单抗（TCZ）治疗葡萄膜炎的成功率。总体而言，在随访12个月的患者中，74.0%的患者在1年后取得了治疗成功（皮下注射77.8%，静脉注射72.2%）。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
